Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Consolidated Net Income (2022 - 2025)

Bioregenx's Consolidated Net Income history spans 4 years, with the latest figure at -$1.0 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$1.0 million for Q4 2025, up 94.47% from a year ago — trailing twelve months through Dec 2025 was -$1.5 million (up 92.51% YoY), and the annual figure for FY2025 was -$1.5 million, up 93.3%.
  • Consolidated Net Income for Q4 2025 was -$1.0 million at Bioregenx, down from -$80565.0 in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$2191.0 in Q3 2022 to a low of -$18.4 million in Q4 2024.
  • The 4-year median for Consolidated Net Income is -$204091.5 (2023), against an average of -$1.4 million.
  • The sharpest move saw Consolidated Net Income plummeted 26695.74% in 2024, then soared 94.47% in 2025.
  • Year by year, Consolidated Net Income stood at -$5535.0 in 2022, then tumbled by 12907.52% to -$719966.0 in 2023, then crashed by 2455.76% to -$18.4 million in 2024, then soared by 94.47% to -$1.0 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at -$1.0 million, -$80565.0, and -$178345.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.